Enter to open, tab to navigate, enter to select
Valeant Pharmaceuticals International, Inc. tender offer for Salix Pharmaceuticals, Ltd.
| February 20, 2015 • Public Merger Agreements • $11.37 billion ($15.8 billion enterprise value). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.